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Angiogenesis requires concomitant remodeling of cell junc-
tions and migration, as exemplified by recent observations of
extensive endothelial cell movement along growing blood ves-
sels. We report that a protein complex that regulates cell junc-
tions is required for VEGF-driven directional migration and for
angiogenesis in vivo. The complex consists of RhoA and Syx, a
RhoA guanine exchange factor cross-linked by the Crumbs
polarity protein Mupp1 to angiomotin, a phosphatidylinositol-
binding protein. The Syx-associated complex translocates to the
leading edge of migrating cells by membrane trafficking that
requires the tight junction recycling GTPase Rab13. In turn,
Rab13 associates with Grb2, targeting Syx and RhoA to Tyr1175-
phosphorylatedVEGFR2 at the leading edge. Rab13 knockdown
in zebrafish impeded sprouting of intersegmental vessels and
diminished the directionality of their tip cells. These results
indicate that endothelial cell mobility in sprouting vessels is
facilitated by shuttling the same protein complex from disas-
sembling junctions to the leading edges of cells.
Several of the major organs in living organisms: the vascular
and lymphatic systems, the lung airways, and the ureteric sys-
tem, to name a few, consist of a tubular network. The develop-
ment of such networks requires recursive remodeling of the
junctions between the mural cells, concurrently with their col-
lective directionalmigration in response to chemotactic factors
(1). A highly dynamic behavior ofmural cells has been observed
in several in vivo and in vitromodel systems. Epithelial cells of
Drosophila tracheal branches undergo extensive rearrange-
ment (2), requiring remodeling of adherens junctions (3). Sim-
ilarly, mural endothelial cells (ECs)5 move extensively during
intersegmental vessel (ISV) sprouting in the zebrafish (4, 5),
during the expansion of the retinal vasculature in the mouse,
and during vessel sprouting from embryoid bodies (5). Junction
remodeling between epithelial and ECs requires endocytosis
and trafficking of junction transmembrane proteins (6). The
recycling of vertebrate adherens and tight junctions ismediated
by the GTPases Rab8 and Rab13, respectively (7).
Recent studies have shown that endocytosis and trafficking
play an important role in facilitating directional cell migration
(8). In mouse neurons, directional migration required Rab5-
and Rab11-dependent trafficking of the adherens junction pro-
tein cadherin (9), similar to epithelial cells in the Drosophila
tracheal system (10). The directional migration of border cells
during Drosophila oogenesis, guided by EGF and PDGF/VEGF
receptor tyrosine kinases, required proteins that mediate
receptor tyrosine kinase endocytosis (11) and Rab11 (12). The
coupling between trafficking and cell migration was high-
lighted in a recent study showing that the activity of Rac, a Rho
GTPase essential for cell migration (13), required Rab5-depen-
dent trafficking (14). Rac was activated on early endosomes,
likely by the guanine exchange factor Tiam1 residing on the
same endosome. Thus, Rab5-dependent trafficking regulated
the spatial activity pattern of Rac and facilitated directional cell
migration by determining where lamellipodia formed.
RhoAparticipates both in the regulation of cell junctions (15)
and in driving cell migration (13), but the mechanism that reg-
ulates the cellular localization of RhoA so as to enable its dual
functions is unknown. The spatial pattern of RhoGTPase activ-
ity in the cell is determined primarily by the localization of Rho
guanine exchange factors, which are often targeted to specific
cellular locations via the binding of their carboxyl terminus
PDZ-binding motif to PDZ domain-containing proteins (16).
In accordance, we had found that the localization the RhoA-
specific guanine exchange factor Syx (named alternatively
Plekhg5 or Tech) and the spatial activity pattern of RhoA
depended on the PDZ-binding motif of Syx (17). Syx binds via
this motif the PDZ domain of the adaptor protein synectin
(named alternativelyGipc1) (17) andPDZdomains 10 and 13 of
multi-PDZ domain protein 1 (Mupp1) (18). Syx is required for
cell migration (17), for angiogenesis in the zebrafish and the
mouse (19), and for the regulation of cell junctions.6 Here we
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report that the functional duality of Syx and RhoA as regulators
of both cell junctions andmigration is conferred by their cotraf-
ficking from EC junctions to the leading edge.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents—Affinity purified anti-Syx was
raised in chicken (Aves Labs) as described (17) and used at 10
mg/ml. Amot antiserum was raised in rabbit (Dr. Earl Poptic,
Hybridoma Core Facility, Lerner Research Institute, Cleveland
Clinic Foundation) against the 24 most carboxyl-terminal
amino acids, as in Ernkvist et al. (21) and used at a 1:1600 dilu-
tion. Antiserum to Mupp1 (a gift of Dr. Ronald Javier, Baylor
College ofMedicine) (22)was used at 1:100 dilution.Antibodies
to Rab13 (Millipore or Santa Cruz Biotechnology), RhoA
(Abcam), Grb2 (Santa Cruz Biotechnology), Tyr(P)1175
VEGFR2 (GenScript), and phalloidin-Alexa647 (Invitrogen)
were used according to the manufacturer’s instructions.
Conjugated secondary antibodies were from Invitrogen
(Alexa 488, 568, and 647), from Jackson ImmunoResearch
(FITC), and from Bio-Rad (peroxidase). Validated lentiviral
shRNA targeting mouse rab13 (CCGGGCCAAGAACG-
ATTCAAGACAACTCGAGTTGTCTTGAATCGTTCTT-
GGCTTTTTG) and negative control lentiviral shRNA
(SHC002V) were purchased from Sigma.
Cell Isolation and Culture—ECs from syx/ and syx/
hearts of adult mice of congenic C57/BL6 background were
isolated as described (23) and maintained up to passage 5 in
DMEM (Lonza Biowhittaker), 20% FBS (Fisher), 1% glutamate
(Invitrogen), 1% nonessential amino acids (Invitrogen), 20
g/ml gentamycin (Sigma), and 100g/ml ECmitogen supple-
ment (Biomedical Technologies). The polyoma middle T-im-
mortalized amot/ and amot/ ECs and their growth con-
ditions were described previously (21).
Immunofluorescence—ECs were grown on fibronectin
(R & D Systems)-coated round (12-mm diameter) glass cover-
slips. Two days before immunolabeling, ECs were starved for
the first day in 0.5% and in serum-free DMEM on the second
day. In part of the experiments, ECs were incubated in starva-
tionmediumat a uniformVEGF-A164 (R & DSystems) concen-
tration of 20 ng/ml on ice for 30 min. At the start of the exper-
iment (0 min), the medium was replaced with fresh starvation
medium prewarmed to 37 °C, and the cells were placed in 37 °C
at 5%CO2 for the durations indicated under “Results.” In Dunn
chamber experiments (see below), the coverslip was placed on
top of the chamber and incubated as above for 30min. ECswere
washed immediately after the coverslip was dismounted by ice-
cold PBS, fixed in 4% paraformaldehyde/PBS for 30 min, and
permeabilized in 10% Triton X-100/PBS for 10 min. ECs
labeled by anti-ZO1 were fixed and permeabilized bymethanol
at 20 °C for 5 min. ECs immunolabeled by anti-Syx under-
went antigen retrieval by 1 min of immersion in boiling 10 mM
sodium citrate, pH 8.6, containing 0.05% Tween 20, instead of
permeabilization. ECs were blocked for 40 min at room tem-
perature by 10% PBS serum of the host species of the secondary
antibody. After immunolabeling by primary antibodies diluted
in PBS overnight at 4 °C, ECs were washed with PBS and incu-
bated with fluorescently tagged secondary antibodies diluted in
PBS for 30 min at room temperature. The coverslips were
mounted on glass slides with Prolong Gold (Invitrogen), a
DAPI-containing medium.
Microscopy—ECs were imaged a Leica TCS-NT confocal
microscope by 63 (1.4 NA) or 40 (1.0 NA) objectives. Cov-
erslips dismounted from Dunn chamber were imaged only
around the region that was directly above the bridge separating
the twowells of the chamber, so as to record only ECs subjected
to the 0–20 ng/ml VEGF-A164 gradient.
FRET Imaging—The adenovirus-encoded FRET RhoA probe
(24) subcloned into pAd/CMV/V5-DEST (Invitrogen) was
coexpressed with lentivirus-encoded rab13-targeted or con-
trol nontargeted shRNA (Mission shRNA; Sigma) 48 h ahead
of the experiment. The coverslips were mounted on top of a
Dunn chamber and imaged either with or without a 0–100
ng/ml VEGF-A164 linear gradient for 5 min at 37 °C on Leica
TCS-NT confocal microscope after paraformaldehyde fixa-
tion. The VEGF concentration and timing followed condi-
tions of peak FRET-detected RhoA activity in previous stud-
ies (24). FRET efficiency was calculated by dividing the
background-subtracted yellow fluorescent protein emission
by the background-subtracted cyan fluorescent protein
emission, using custom-written macros in Image-Pro 7.0
(Media Cybernetics). A total of 40 ECs treated by nontarget-
ing or by rab13-targeted shRNA were imaged in each group.
The direction of the FRET pattern polarization was deter-
mined by eye.
Quantification of Colocalization and of Polarization of Cel-
lular Proteins—Colocalization was quantified by CoolLocalizer
(Cytolight, Stockholm, Sweden), based onPearson’s correlation
coefficient (25). The polarization of the colocalization pattern
was determined bymeasuring the colocalization level in each of
six 60-degree sectors. The center of the first sector was aligned
in the gradient direction and designated as 0 degrees. Colocal-
ization was calculated in 10 ECs from at least two experiments
and presented as a radial graph of themeans and standard devi-
ations of the colocalization level in each sector. The significance
of the difference (p) was determined by a two-sample t test of
the sectors with the highest and the second highest colocaliza-
tion levels.
Immunoprecipitation—Confluent ECs grown in a 35-mm
dish were lysed in 250 l of lysis solution (Cytoskeleton) and
incubated with 1 g of anti-Rab13 (Santa Cruz Biotechnology)
overnight at 4 °C. Antibody-bound complexes were precipi-
tated with protein G-Sepharose beads (Santa Cruz Biotechnol-
ogy) and eluted by boiling the thoroughly washed beads in SDS
sample buffer. Eluted proteins were resolved on 12% SDS-
PAGE gel (Bio-Rad), transferred to a PVDFmembrane (Pierce)
at 25V for 1 h, and detected by anti-Grb2 (Santa Cruz) followed
by peroxidase-conjugated goat anti-mouse IgG (Bio-Rad).
Immunoblotted bands were detected by exposure to BioMax
XAR film (Kodak).
Dunn Chamber Chemotaxis Assay—The Dunn chamber and
its assembly were described in detail before (26). Approxi-
mately 104 primary mouse heart ECs were seeded on fibronec-
tin-coated square glass coverslips and starved overnight prior
to the assay. Both concentric wells of the chamber were filled
with starvation medium (DMEMwith 0.5% BSA), and a cover-
slip seededwith ECs was inverted onto the chamber in an offset
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position leaving a narrow slit at one edge for refilling the outer
well. The coverslipwas sealed in place using a 60 °C-meltedwax
mixture (paraffin, beeswax, Vaseline, 1:1:1) around the edges,
except for the filling slit. To set up a linear radially directed
VEGF-A164 gradient, themedium in the outer well was drained
and replaced by starvation medium containing 0.5% BSA and
20 ng/ml VEGF-A164. The slit was then sealed by hot wax mix-
ture. For control experiments in which ECs were subjected to
uniform concentrations of chemoattractant, both wells were
filledwithmediumcontainingVEGF (20ng/ml).Migrating ECs
were imaged on Leica DM IRB inverted microscope equipped
with CoolSnap HQ cooled CCD camera (Photometrics) on a
motorized stage (Prior Scientific) prewarmed to 37 °C. Stage
positions were preprogrammed by MetaMorph 6.3r2 software
(Molecular Devices). The Dunn chamber assembly was prein-
cubated for 30min to let its temperature equilibrate and a linear
gradient to form between the outer and inner wells. The cover-
slip region laying directly above the circular ridge separating
the outer and inner wells was imaged every 5 min for 1 h. The
trajectories of migrating ECs were tracked manually, and their
X-Y positions were input into Image-Pro for path plotting and
analysis. The probability of the null hypothesis (that the migra-
tion of the 20–50 ECs sampled in each experiment was not
directional) was determined by Rayleigh test for unimodal clus-
FIGURE 1. Syx was required for directional migration in response to VEGF and colocalized with Rab13. A–C, the migration of syx/ and syx/ ECs did not
have a predominant direction in the absence (A) or presence (B) of a uniform concentration of VEGF-A164 (20 ng/ml). Under a 0 –20 ng/ml VEGF-A164 gradient
(C), syx/ ECs migrated preferentially (red arrow in circular histogram represents mean direction; the green region represents 95% confidence interval) along
the gradient direction (the x axis), whereas syx/ ECs did not. x and y axis units are m; total time, 240 min; p, probability of absence of a predominant direction,
based on Raleigh test, n  50 –100. D, endogenous Syx was localized mainly to the cell periphery and cell junctions in confluent cells (arrowheads) and partially
to cytoplasmic punctae (arrows). E, Syx and Rab13 appeared as cytoplasmic punctae in quiescent ECs. F, Syx and Rab13 colocalized within 2 min of VEGF-A164
stimulation (20 ng/m). G, under a VEGF-A164 gradient, Syx and Rab13 colocalized at the leading edge facing the gradient direction (arrow). H, quantification of
the angular distribution of Syx and Rab13 colocalization in ECs subjected to a VEGF-A164 gradient (0 –20 ng/m). The gradient direction is 0 degrees (mean  S.D.,
n  10, p  0.007). Bars, 10 m.
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tering (27). The 95% confidence interval of the mean direction
was calculated using a Batschelet chart (27).
Zebrafish Protocols—Zebrafish were maintained, and the
embryos were imaged as described (28). Morpholino antisense
oligonucleotides (MOs) were designed and purchased from by
GeneTools. The MO1 sequence spans the rab13 ATG codon:
GAAGTCGTACTTCTTTGCCATTGTT. MO2 targets the
rab13 exon 2-intron 2 border: AGAATCTTTGTTTACCA-
GACTTGCA. A 5-base pair mismatch of MO2 with the
sequence AGAATGTTTCTTTAGCACACTTCCA served as
negative control.
RESULTS
syx/ ECs Fail to Follow a VEGF-A165 Gradient—To inves-
tigate the mechanism underlying the angiogenic defects we
detected previously in the syx/ mouse and in the zebrafish
syx morphant (19), we compared the directional response of
syx/ and syx/ ECs induced by VEGF-A164. An angiogene-
sis paradigm generalized from observations of vascular devel-
opment in the retina (29) posits that sprouting vessels follow a
VEGF gradient. To simulate the in vivo conditions, we sub-
jected ECs to a VEGF-A164 gradient (0–20 ng/ml) in a Dunn
chemotaxis chamber (27). The basal migration distances of
syx/ and syx/ ECs in the absence of VEGF-A were simi-
larly low (Fig. 1A). Both cell types migrated in response to a
uniform VEGF-A164 concentration, although the distances
traveled by syx/ ECs were shorter than those traveled by
syx/ ECs (Fig. 1B), similar to our previous observations (19).
The responses of the two cell types to a VEGF-A164 gradient
were drastically different from each other: syx/ EC followed
the direction of the gradient, whereas syx/ ECs failed to
respond in a directional manner (Fig. 1C). The difference
between the responses of syx/ EC and syx/ ECs cannot be
accounted for by a lower VEGFR2 expression level in the latter
(supplemental Fig. S1). These results indicate that Syx is
required for EC directional migration.
Syx Colocalizes with Rab13 on Endocytic Vesicles—We have
recently found that Syx is required for the maintenance of
endothelial and epithelial cell junctions.6 We had found earlier
that Syx was localized to the leading edge of migrating ECs and
that it was required for EC migration (17, 19). Syx associates
through the PDZ adaptor protein synectin withmyosin VI (17),
an actin-based molecular motor involved in membrane traffic
(30). This association implies that Syx could traffic, possibly
facilitating its translocation from cell junctions to the leading
edge and enabling its involvement in the regulation of both cell
junctions and migration. In quiescent ECs, Syx was localized
primarily at cell junctions and in the cytoplasm (Fig. 1D).
Immunofluorescence revealed that stimulation by VEGF-A164
induced the appearance of Syx primarily in cytoplasmic punc-
tae (Figs. 1F and 2B). We used standard endocytic markers to
test whether these punctae represented endocytic vesicles. The
Syx-containing punctae did not colocalize, however, with clath-
rin heavy chain, AP3, Rab5, EEA1, Rab4, and Rab11 (data not
shown). Because Syx is localized to cell junctions of confluent
cells, we immunolabeled VEGF-treated ECs for Rab13, a
GTPase known to be involved in recycling the tight junction
transmembrane proteins occludin (31) and claudin-1 (32).
Although Syx and Rab13 did not colocalize in quiescent ECs
(Fig. 1E), treatment with a uniform VEGF-A164 concentration
induced extensive colocalization throughout the cytoplasm
within the first 2 min (Fig. 1F). This is in agreement with previ-
ous studies reporting that in unpolarized cells, such as the ECs
FIGURE 2. Syx and RhoA colocalized in response to VEGF. A, there was little
colocalization of Syx and RhoA in quiescent ECs. B, Syx and RhoA colocalized
on endocytic vesicles within 2 min of stimulation by 20 ng/ml VEGF-A164.
C, Syx and RhoA polarized in the direction of the VEGF-A164 gradient (0 –20
ng/m) and colocalized on endocytic vesicles. D, quantification of the extent
and angular distribution of Syx and RhoA colocalization in ECs subjected to a
VEGF-A164 gradient (0 –20 ng/m). The gradient direction is 0 degrees (mean 
S.D., n  10; p  0.0001). Bars, 10 m.
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shown in Fig. 1 (D–G), Rab13 is present exclusively in cytoplas-
mic vesicles (33). When placed under a VEGF-A164 gradient
(0–20 ng/ml) in aDunn chamber, ECs formed lamellipodia and
polarized in the gradient direction (Fig. 1G). Strikingly, Rab13
and Syx colocalized at the leading edge within 30 min. The
extent of colocalization between Rab13 and Syx was highest in
the 60-degree sector facing the gradient direction (Fig. 1H),
indicating that the VEGF-A164 gradient polarized the colocal-
ization pattern of Syx andRab13. The localization at the leading
edge suggests that similar to Syx, Rab13 has a multifaceted role
that includes trafficking of junction proteins to the leading edge
of migrating cells.
RhoA Colocalizes with Syx on Endocytic Vesicles—Because
Syx is a RhoA-specific GTPase (18, 34), we sought to determine
the localization of its effector. There was little colocalization
between Syx and RhoA in quiescent ECs (Fig. 2A). In contrast, a
uniform VEGF-A164 concentration (20 ng/ml) induced exten-
sive colocalization of Syx and RhoA on endocytic vesicles
within 2min (Fig. 2B). The localization of Syx and RhoA in ECs
under VEGF-A164 gradient was polarized in the gradient direc-
tion, mainly at the leading edge (Fig. 2C). The extent of colocal-
ized Syx and RhoA in the frontal 60-degree sector was more
than 2-fold higher than in all other 60-degree sectors (Fig. 2D).
Rab13 Is Required for Directional Migration, for Syx and
RhoA Trafficking, and for the Polarization of Activated RhoA—
To investigate the dependence of EC directional migration and
Syx trafficking on Rab13, we knocked down rab13 by shRNA
(supplemental Fig. S2). The migration of Rab13-deficient ECs
in response to a VEGF-A164 gradient was not directional, sim-
ilar to that of syx/ ECs (Fig. 3A), suggesting that Rab13-de-
pendent trafficking of Syx and RhoA is required formaintaining
directional migration. In agreement, Syx and RhoA did not colo-
calize in Rab13-deficient ECs neither under uniform VEGF-A164
(Fig. 3B) nor under a VEGF-A164 gradient (Fig. 3C). These results
show thatRab13 is required forVEGF-guidedmigration, aswell as
forSyxandRhoAtrafficking. Inaddition to its role in tight junction
recycling,Rab13mediates traffic between the trans-Golgi network
and recycling endosomes (35). Because all of the Syx-associated
proteins are cytoplasmic rather than transmembrane receptors,
they are not expected to traffic via the trans-Golgi network. It is
unlikely, therefore, that the directional migration and trafficking
defects caused by rab13 silencing resulted from impairment of
FIGURE 3. Rab13 was required for directional migration and Syx trafficking. A, ECs in which rab13 had been silenced did not migrate predominantly along
the VEGF-A164 0 –20 ng/ml gradient (represented by the X direction). B and C, rab13 silencing prevented colocalization of Syx and RhoA on endocytic vesicles
in VEGF-A164-treated (20 ng/ml) (B) ECs and in ECs subjected to a 0 –20 ng/ml VEGF-A164 gradient. (C), Syx and RhoA traffic was normal in ECs transfected by
control shRNA (data not shown). D and E, FRET efficiency images of ECs (four cells of 40 in each group) transfected by nontargeting (D) or by rab13-targeted
shRNA (E). A solid arrow denotes the direction of the VEGF gradient; a dashed arrow denotes the mean direction of FRET pattern polarization, if such a pattern
was manifest. The circular histograms show the average direction (red arrow) and its standard deviation (green sector) for each group, relative to the gradient
direction (black arrow). The FRET pattern was polarized in 20 of 40 cells transfected by nontargeting shRNA at a mean direction of 18.4  10.5 degrees, whereas
it was polarized only in four of 40 cells transfected by rab13-targeted shRNA at a mean direction of 87  41.8 degrees. Scale bars, 10 m.
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Rab13-dependent traffic from the trans-Golgi network to recy-
cling endosomes.
The dependence of Syx and RhoA trafficking on Rab13 sug-
gests that the spatial pattern of RhoA activity may similarly
depend onRab13-mediated trafficking. To test this premise, we
used a FRET probe consisting of the Rho-binding domain of
rhotekin, cyan fluorescent protein, yellow fluorescent protein,
and RhoA (24). The probe detects RhoA-specific guanine
exchange factor activity. In 50% of ECs transfected by nontar-
geting shRNA and stimulated by VEGF-A164 in a Dunn cham-
ber, the FRET spatial pattern was polarized at a mean direction
of 18.4  10.5 degrees relative to the gradient direction (Fig.
3D). Active RhoA was localized to either cytoplasmic punctae
or along the leading edge, similar to RhoA localization (Fig. 2C)
and to the RhoA activity pattern reported by previous FRET
studies (36, 37). The FRET pattern was polarized only in 10% of
ECs transfected with rab13-targeted shRNA, at a mean direc-
tion of 87  41.8 degrees (Fig. 3E), i.e. without a directional
preference. These results confirm the dependence of the spatial
pattern of RhoA activity on Rab13.
Angiomotin Is Required for the Recruitment of Syx to Endo-
cytic Vesicles—In a recent study, we proposed a molecular
mechanism to account for the VEGF-induced removal of Syx
from tight junctions.6 Similar to other junctional proteins (9,
31), the removal of Syx from cell junctions is likely mediated by
Rab13-dependent vesicle trafficking, but the recruitment
mechanism of Syx to vesicles is unknown. It is unlikely that Syx
is recruited to vesicles by its pleckstrin homology domain,
because such domains favor binding to phosphatidylinositol
3,4,5-phosphate, whereas the prevalent phosphoinositide-
phosphate in endosomal membranes is phosphatidylinositol
3-phosphate (38). Mupp1, which binds Syx directly (18, 39),
cross-links Syx to Amot (39, 40). Because Amot has a lipid-
binding domain that favors mono- over di- or tri-phosphory-
lated phosphatidylinositols (41), it could recruit Mupp1 and Syx
to vesicles. The colocalization ofAmotwith Syx (Fig. 4,A andB)
and with Rab13 (supplemental Fig. S3) increased after treat-
ment with VEGF-A164. Furthermore, Mupp1 also colocalized
with vesicular Syx (Fig. 4C), suggesting the presence of a Syx-
Mupp1-Amot complex on endocytic vesicles. The recruitment
of the Syx-Mupp1-Amot complex to vesicles likely occurs
before the VEGF-induced decrease in binding of Syx to
Mupp1.6 To test whether Amot targets Syx to endocytic vesi-
cles, we imaged Syx in quiescent and VEGF-A164-treated
amot/ and amot/ ECs. In the absence of Amot, the local-
izations of Syx andRab13weremarkedly different from those in
amot/ECs (Fig. 4D). Their level of colocalization in amot/
was lower than in amot/ ECs, andmost of the Rab13 cellular
population in amot/ ECs was associated with tubular struc-
tures that reached a length of 5 m rather than with round
vesicles. These results indicate that Amot is required not only
for the recruitment of Syx to endocytic vesicles but also for
structuring the intracellular membranes that support Rab13-
dependent trafficking. Synectin did not appear to be involved in
the recruitment of Syx to endocytic vesicles in response to
VEGF, because the colocalization of the two proteins was very
low (data not shown).
Rab13 and Syx Are Targeted to the Leading Edge of VEGF-A-
treated ECs by Grb2—The translocation of Syx and Rab13 to
the leading edge of ECs subjected to a VEGF gradient (Fig. 1F)
implies the presence of a targeting motif at that location.
Because VEGF induces endocytosis of VEGFR2 at the leading
edge (42), the cytoplasmic domain of the internalized receptor
could conceivably recruit Syx-carrying vesicles. In agreement,
we found that Syx colocalized with Tyr1175-phosphorylated
VEGFR2 at the leading edge (Fig. 5A). The extent of colocaliza-
tion in the 60-degree sector facing the VEGF gradient was
2-fold higher than in any other 60-degree sector (Fig. 5B).We
FIGURE 4. Amot colocalized with Syx and was required for Syx trafficking.
A and B, Amot colocalized with Syx in quiescent (A) and VEGF-A164-stimu-
lated (20 ng/m) ECs (B). C, Syx colocalized also with Mupp1 in similarly stimu-
lated ECs. D, knockdown of Amot reduced the colocalization of Syx and Rab13
and caused appearance of Rab13-associated tubules (arrowheads). Scale bars,
10 m.
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next sought to identify the protein that docks the Syx-carrying
vesicles to Tyr(P)-VEGFR2 at the leading edge. Because Rab13
is not known to bind VEGFR2 directly, we searched for other
proteins that could dock Syx-carrying vesicles to Tyr(P)-
VEGFR2. Rab13 binds the cell junction protein molecule inter-
acting with CasL-like 2 (MICAL-L2) (43). MICAL-L2 binds, in
turn, actinin-4 (60), which interacts with Grb2 (61). Grb2 binds
the adaptor protein growth factor receptor binding protein 2
(Grb2) (44). Grb2 has the capacity to recruit other proteins to
activated VEGFR2 because its Src homology 2 domain binds
phosphorylated tyrosines in the cytoplasmic domains of several
receptor tyrosine kinases, including VEGFR2 (45). In agree-
ment, Rab13, Syx, and Grb2 colocalized in the frontal lamelli-
podia of VEGF-stimulated ECs but were absent from the lead-
ing edge of untreated, spontaneously polarized ECs (Fig. 5, C
and D). Importantly, Rab13 and Grb2 coimmunoprecipitated
from EC lysates (Fig. 5E), showing that Rab13-carrying vesicles
can be targeted to Tyr(P)-VEGFR2 at the leading edge by a
Rab13 and Grb2-containing complex.
Rab13 Is Required for ISV Growth in the Zebrafish—The
zebrafish Rab13 ortholog has 78% sequence identity to mouse
Rab13, and its mRNA is expressed in vessels of the trunk (46).
To study the function of Rab13 in ISV sprouting, we knocked
rab13 down in transgenic Tg(flk1:EGFP) zebrafish. Embryos
were injected at the one-cell stage by MO1 or MO2, targeting
the start codon and the exon 2-intron 2 splicing site, respec-
tively. By 28 h postfertilization, part of the ISVs of embryos
injected by nontargeting control MO were fully grown and
FIGURE 5. Targeting of Syx to Tyr(P)1175-VEGFR2 by Grb2. A, Syx localization was not polarized in quiescent ECs, and the Tyr(P)1175-VEGFR2 signal at the cell
edges was low. In ECs subjected to a VEGF-A164 gradient (0 –20 ng/m), Syx colocalized with Tyr(P)
1175-VEGFR2 (pY-R2) at the leading edge. B, quantification of
the extent and angular distribution of Syx and Tyr(P)1175-VEGFR2 colocalization in ECs subjected to a VEGF-A164 gradient (0 –20 ng/m). The gradient direction
is 0 degrees (mean  S.D., n  10, p  0.0001). C, Syx, Rab13, and Grb2 were absent from the leading edge of untreated spontaneously polarized ECs. A
VEGF-A164 gradient (0 –20 ng/m) induced colocalization of the three proteins in frontal lamellipodia (arrowheads). D, quantification of the colocalization of Grb2
with Rab13 within a distance of 5 m from the leading edge of untreated ECs and of ECs subjected to a 0 –20 ng/m VEGF-A164 gradient (mean  S.D., n  10,
p  3  107). E, the extent of Rab13 coimmunoprecipitated with Grb2 (molecular mass  25.2 kDa) was higher in ECs treated by VEGF-A164 (20 ng/ml, 5 min).
Scale bars, 10 m.
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started coalescing into the dorsal anastomotic longitudinal ves-
sel (Fig. 6B). In zebrafish embryos injected by either MO1 or
MO2, however, ISVs stopped growing approximately midway
between the dorsal aorta and the would-be location of the
unformed dorsal anastomotic longitudinal vessel (Fig. 6B). The
lengths of the ISVs and the shape of their tips were variable
(right-hand panels in Fig. 6A), unlike the growth-arrested ISVs
in syx and amotmorphants that ended uniformly in a round tip
(19, 47). These observations conform to a scenario in which the
loss of directional migration caused by Rab13 depletion ran-
domizes the shape of the tips cells of sprouting ISVs. The pen-
etrance of the ISV defects induced by MO1 and MO2 was 47
and 50%, respectively, versus 7% of the embryos injected by the
controlMO (Fig. 6B). The loss of tip directionality is consistent
with the directional defect in cell migration caused also by
rab13 knockdown (Fig. 3A). The absence of dorsal aorta defects
suggests that Rab13 is specifically required for angiogenesis and
is not involved in vasculogenesis.
DISCUSSION
Accumulating evidence indicates that membrane traffic is
tightly integrated into cell migration (8, 48). Whereas it is
appreciated that directional cell migration requires trafficking
of adhesion and growth factor receptors (8), including that of
VEGFR2 (42, 49, 50), the dependence of directional migration
on trafficking of cytoskeletal and motility proteins has come to
light only recently. Our finding that Rab13-dependent traffick-
ing of Syx and RhoA is required for directional cell migration
resonates with a recent report on the requirement of Rab5-de-
pendent trafficking of Rac and Tiam1 for hepatocyte growth
factor-stimulated migration of mouse embryo fibroblasts (14).
Interestingly, our results suggest that Rac and RhoA traffic
along separate pathways. This previously unknown difference
between Rac and RhoA indicates that the cellular targeting of
Rac and RhoA, and hence their spatial activity patterns, are
determined by different mechanisms. Although the targeting
mechanismof Rac is unknown, our data describe howGrb2 and
Tyr-phosphorylated VEGFR2 target RhoA to the leading edge
of migrating cells. Grb2 binds to Tyr(P) not only of VEGFR2
(45) but also of EGFR, PDGFR (51), and FGF receptor (52).
Consequently, the Grb2-dependent targeting of RhoA to the
leading edge of migrating cells may be a general mechanism
shared by several growth factors and present in multiple cell
types. Depletion ofGrb2 has indeed been shown to decrease the
EGF-induced migration of fibroblasts and macrophages (53).
Based on in vitro experiments with synthetic lipid mem-
branes, a recent study attributed liposome tubulation activity to
a region in the amino terminus of Amot (41). Although our
findings also indicate that Amot structures intracellular mem-
branes, we observed that amot/ ECs contained numerous
Rab13-associated tubular structures (Fig. 5D). This indicates
that Amot may cooperate with dynamin in vesicle fission, sim-
ilar to amphiphysin (54), rather than form tubules. Because
other membrane-molding proteins bind Rho and Rab GTPases
(55), it is possible that Amot targets RhoA and Rab13 to endo-
cytic vesicles, in addition to recruitingMupp1/Patj (41) and Syx
(this study). The multifunctionality of Amot, including its
involvement in the regulation of Cdc42 via the GTPase-activat-
ing protein Rich1 (56), highlights Amot as pivotal adaptor pro-
tein in the intersection between trafficking, cell junctions, and
cell migration. Whereas the colocalization of Amot and Rab13
on perinuclear endosomes was observed before (41), we find
that Amot and Rab13 colocalize extensively on endocytic vesi-
cles throughout the cytoplasm. Unlike the study of Heller et al.
(41), we did not observe colocalization of Amot and Rab11.
FIGURE 6. rab13 knockdown caused ISV defects. A, images of the vasculature in the trunk of Tg(flk1:EGFP) embryos injected by 12 ng each of a five-base
mismatch control MO (Mis) or MOs targeting the ATG codon (MO1) and the exon 2-intron 2 splicing site (MO2). The embryos were fixed at 28 h postfertilization.
B, quantification of the penetrance of the mismatch MO, of MO1, and of MO2 in groups of 44, 75, and 80 embryos, respectively.
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However, Amot-Rab11 colocalization occurred only in unpo-
larized epithelial cells, whereas we focused on ECs. We previ-
ously reported that the polarization of active RhoA inmigrating
ECs required the Amot-Mupp1/Patj-Syx complex (39). The
dependence of Syx recruitment to endocytic vesicles on Amot,
which we report here, explains that finding.
The colocalization of the Crumbs complex protein Mupp1
with Syx on endocytic vesicles in VEGF-stimulated ECs could
account for the presence of the Mupp1 paralog Pals1-associ-
ated tight junction protein (Patj) at the leading edge of migrat-
ing epithelial cells and for its involvement in directional cell
migration (57). Similarly, the role of Amot in Rab13-dependent
trafficking of Syx and RhoA may explain how Amot regulates
both cell migration and cell junctions (58). The involvement of
Patj/Mupp1 and Amot in the regulation of directional cell
migration conveys a common theme whereby junctional pro-
teins are required also for cell migration, a seemingly counter-
intuitive notion. However, the functional versatility of these
proteins and their alternate localization at cell junctions and at
the leading edge are probably essential for conferring the
dynamic cell remodeling inherent to growing vessels, where the
same cell regions may alternate between being a leading edge
and forming junctions. Amot and Syx had already been shown
to be required for vascular development in the mouse and
zebrafish (19, 47).
Our findings suggest a distinct scenario for the regulation of
directional cell migration by Rab13-dependent trafficking of
Syx and its effector, RhoA (Fig. 7): 1) the binding of VEGF-A to
VEGFR2 initiates signals, still unidentified, that trigger endocy-
tosis of junctional transmembrane receptors, likely in a clathrin-
dependentmanner (59), andAmot recruits the Syx-Mupp1-RhoA
complex to endocytic vesicles harboring junctional transmem-
brane receptors; 2) Rab13 associates with and mediates the traf-
ficking of these vesicles; it recruits Grb2 through binding
MICAL-L2 and actinin-4; and 3)Grb2 targets these vesicles to the
Tyr-phosphorylatedcytoplasmicdomainof internalizedVEGFR2;
Syx activates RhoA residing on the same vesicle, near the leading
edge of migrating cells. In this manner, Rab13-mediated traffick-
ing of the Syx-associated protein complex could sustain move-
ment of mural ECs in sprouting vessels.
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folter, M. (2008) Dev. Biol. 316, 312–322
5. Jakobsson, L., Franco, C. A., Bentley, K., Collins, R. T., Ponsioen, B., As-
palter, I. M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A., Schulte-
Merker, S., and Gerhardt, H. (2010) Nat. Cell. Biol. 12, 943–953
6. Yap,A. S., Crampton,M. S., andHardin, J. (2007)Curr.Opin. Cell. Biol.19,
508–514
7. Yamamura, R., Nishimura, N., Nakatsuji, H., Arase, S., and Sasaki, T.
(2008)Mol. Biol. Cell 19, 971–983
8. Ulrich, F., and Heisenberg, C. P. (2009) Traffic 10, 811–818
9. Kawauchi, T., Sekine, K., Shikanai, M., Chihama, K., Tomita, K., Kubo, K.,
Nakajima, K., Nabeshima, Y., and Hoshino, M. (2010) Neuron 67,
588–602
10. Shaye, D. D., Casanova, J., and Llimargas, M. (2008) Nat. Cell. Biol. 10,
964–970
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